Clinical Trials Directory

Trials / Unknown

UnknownNCT05648955

Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment

Muscle Mass in Patients With Colorectal or Lung Cancer When Receiving an Oral Nutritional Supplement During Anti-cancer Treatment

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
118 (estimated)
Sponsor
Nutricia Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition and low muscle mass (sarcopenia) are common problems in patients with cancer. However, a low muscle mass is associated with negative clinical outcomes in patients with cancer. Therefore, it is very important to maintain muscle mass in this population. This study aims to investigate the effect of an oral nutritional supplement on skeletal muscle mass during anti-cancer treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTan enriched high protein and high energy oral nutrition supplement (ONS)NA (see intervention name)

Timeline

Start date
2023-03-31
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2022-12-13
Last updated
2023-07-28

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT05648955. Inclusion in this directory is not an endorsement.

Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment (NCT05648955) · Clinical Trials Directory